| Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects MI Mohammed Abdul, X Jiang, KM Williams, RO Day, BD Roufogalis, ... British journal of pharmacology 154 (8), 1691-1700, 2008 | 198 | 2008 |
| Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide H Xu, KM Williams, WS Liauw, M Murray, RO Day, AJ McLachlan British journal of pharmacology 153 (7), 1579-1586, 2008 | 145 | 2008 |
| Ethnic differences in drug metabolism and toxicity from chemotherapy VH Phan, MM Moore, AJ McLachlan, M Piquette-Miller, H Xu, SJ Clarke Expert opinion on drug metabolism & toxicology 5 (3), 243-257, 2009 | 139 | 2009 |
| Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics V Perera, AS Gross, H Xu, AJ McLachlan Journal of Pharmacy and Pharmacology 63 (9), 1161-1168, 2011 | 90 | 2011 |
| Vancomycin pharmacokinetics in patients with severe burn injuries M Dolton, H Xu, E Cheong, P Maitz, P Kennedy, T Gottlieb, E Buono, ... Burns 36 (4), 469-476, 2010 | 83 | 2010 |
| Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design CB Landersdorfer, NS Ly, H Xu, BT Tsuji, JB Bulitta Antimicrobial agents and chemotherapy 57 (5), 2343-2351, 2013 | 82 | 2013 |
| Predictive performance of physiologically based pharmacokinetic and population pharmacokinetic modeling of renally cleared drugs in children W Zhou, TN Johnson, H Xu, SYA Cheung, KH Bui, J Li, N Al‐Huniti, ... CPT: pharmacometrics & systems pharmacology 5 (9), 475-483, 2016 | 66 | 2016 |
| Predictive performance of physiologically based pharmacokinetic (PBPK) modeling of drugs extensively metabolized by major cytochrome P450s in children W Zhou, TN Johnson, KH Bui, SYA Cheung, J Li, H Xu, N Al‐Huniti, ... Clinical Pharmacology & Therapeutics 104 (1), 188-200, 2018 | 64 | 2018 |
| Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects MIM Abdul, X Jiang, KM Williams, RO Day, BD Roufogalis, WS Liauw, ... British Journal of Clinical Pharmacology 69 (5), 508-515, 2010 | 55 | 2010 |
| Influence of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of sulfonylurea drugs H Xu, M Murray, AJ McLachlan Current drug metabolism 10 (6), 643-658, 2009 | 55 | 2009 |
| Indoor air pollution levels in decorated residences and public places over Xi’an, China T Chang, D Ren, Z Shen, Y Huang, J Sun, J Cao, J Zhou, H Liu, H Xu, ... Aerosol and Air Quality Research 17 (9), 2197-2205, 2017 | 53 | 2017 |
| Stereoselective analysis of hydroxybupropion and application to drug interaction studies H Xu, KK Loboz, AS Gross, AJ McLachlan Chirality: The Pharmacological, Biological, and Chemical Consequences of …, 2007 | 36 | 2007 |
| Seasonal and diurnal variation of PM2. 5 HULIS over Xi'an in Northwest China: Optical properties, chemical functional group, and relationship with reactive oxygen species (ROS) T Zhang, S Huang, D Wang, J Sun, Q Zhang, H Xu, SSH Ho, J Cao, ... Atmospheric Environment 268, 118782, 2022 | 29 | 2022 |
| Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based … L Zhou, P Sharma, KR Yeo, M Higashimori, H Xu, N Al-Huniti, D Zhou European Journal of Pharmaceutical Sciences 139, 105061, 2019 | 29 | 2019 |
| An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs VH Phan, C Tan, A Rittau, H Xu, AJ McLachlan, SJ Clarke Expert opinion on drug metabolism & toxicology 7 (11), 1395-1410, 2011 | 29 | 2011 |
| Explorations of tire and road wear microplastics in road dust PM2. 5 at eight megacities in China J Sun, SSH Ho, X Niu, H Xu, L Qu, Z Shen, J Cao, HC Chuang, KF Ho Science of the Total Environment 823, 153717, 2022 | 27 | 2022 |
| Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients N Al‐Huniti, S Chapel, H Xu, KH Bui, M Sostek British Journal of Clinical Pharmacology 81 (1), 89-100, 2016 | 26 | 2016 |
| Bridging olaparib capsule and tablet formulations using population pharmacokinetic meta-analysis in oncology patients D Zhou, J Li, K Bui, M Learoyd, A Berges, T Milenkova, N Al-Huniti, ... Clinical pharmacokinetics 58, 615-625, 2019 | 25 | 2019 |
| Optical properties, molecular characterizations, and oxidative potentials of different polarity levels of water-soluble organic matters in winter PM2. 5 in six China's megacities T Zhang, Z Shen, S Huang, Y Lei, Y Zeng, J Sun, Q Zhang, SSH Ho, H Xu, ... Science of the Total Environment 853, 158600, 2022 | 20 | 2022 |
| Optical properties, chemical functional group, and oxidative activity of different polarity levels of water-soluble organic matter in PM2. 5 from biomass and coal combustion in … S Huang, Y Luo, X Wang, T Zhang, Y Lei, Y Zeng, J Sun, H Che, H Xu, ... Atmospheric Environment 283, 119179, 2022 | 20 | 2022 |
